
Assessment of peripheral blood protein glycosylation has recently become scalable, providing a new domain for biomarker research.
Klaus Lindpaintner, MD, MPH is chief scientific officer and distinguished scientist at InterVenn BioSciences.

Assessment of peripheral blood protein glycosylation has recently become scalable, providing a new domain for biomarker research.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
